Journals / Retina-Vitreus / 2018 / Cilt: 27 - Sayı: 3

Bilateral Acute Central Serous Chorioretinopathy with Prominent Serous Retinal Detachment: Differential Diagnosis with Early Vogt-Koyanagi-Harada Disease

Belirgin Seröz Dekolmanla Bulgu Veren Bilateral Akut Santral Seröz Koryoretinopati: Başlangıç Vogt-Koyanagi- Harada Hastalığı ile Ayırıcı Tanı

Pages
283–287
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We hereby report a patient with bilateral CSCR who has been admitted to our clinic with a preliminary diagnosis of VKH disease and discuss differential diagnosis of these entities based on clinical fi ndings and imaging modalities.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Acute central serous chorioretinopathy (CSCR) is a disorder usually characterized with neurosensorial retinal detachment.
📊
Key Findings & Data:Glucocorti- coids have critical importance in the pathogenesis of the disease.
💡
Conclusion & Impact:We hereby report a patient with bilateral CSCR who has been admitted to our clinic with a preliminary diagnosis of VKH disease and discuss differential diagnosis of these entities based on clinical fi ndings and imaging modalities.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Acute central serous chorioretinopathy (CSCR) is a disorder usually characterized with neurosensorial retinal detachment. Glucocorti- coids have critical importance in the pathogenesis of the disease. CSCR with bilateral simultaneous involvement and prominent serous retinal detachment can be observed following prolonged and high-dose corticosteroid treatment. New-onset Vogt-Koyanagi-Harada disease and CSCR may be presented with similar clinical manifestations. Differential diagnosis of these disorders have great clinical importance in order to avoid severe vision loss. We hereby report a patient with bilateral CSCR who has been admitted to our clinic with a preliminary diagnosis of VKH disease and discuss differential diagnosis of these entities based on clinical fi ndings and imaging modalities.

Özet

Akut santral seröz koryoretinopati (SSKR) nörosensoriyal retinanın seröz dekolmanı ile karakterize bir hastalıktır. SSKR patogenezinde glukokortikoidler kritik öneme sahiptir. Özellikle yüksek doz ve uzun süreli kortikosteroid tedavisi ile akut bilateral ve belirgin seröz dekolmanın eşlik ettiği ağır hastalık tabloları ile karşılaşılmaktadır. SSKR ile başlangıç Vogt-Koyanagi-Harada (VKH) hastalığında benzer bulgular görülebilir. Bu iki hastalığın ayırıcı tanısı ciddi görme kayıplarına neden olabilecek komplikasyonların önlenmesi açısından kritik öneme sahiptir. Bu yazıda VKH ön tanısıyla tedavi edilmek üzere kliniğimize yönlendirilen bilateral SSKR’li bir hasta sunularak bu iki hastalığın klinik ve görüntüleme yöntemleri ile ayırıcı tanısı ayrıntılı olarak tartışılacaktır.

🔖

Cite This Article

ŞEKEROĞLU, M. A., DOĞUİZİ, S., YILMAZBAŞ, P. (2018). Bilateral Acute Central Serous Chorioretinopathy with Prominent Serous Retinal Detachment: Differential Diagnosis with Early Vogt-Koyanagi-Harada Disease. Retina-Vitreus, Cilt: 27 - Sayı: 3, 283–287. https://ajindex.com/articles/308119

References (10)

  1. Yaylacıoğlu Tuncay F, Gürelik G. Santral seröz koryoretinopati. Ret-Vit 2010;18:85-111.
  2. Jampol LM, Weinreb R, Yannuzzi L. Involvement of corticostero- ids and catecholamines in the pathogenesis of central serous cho- rioretinopathy: A rationale for new treatment strategies. Ophthal- mology 2002;109:1765-6.
  3. Artunay HO, Rasier R, Yüzbaşıoğlu E ve ark. Göz çevresi cilt bölgesine uygulanan topikal glukokortikoid tedavisi sonrası ge- lişen akut bilateral santral seröz koryoretinopati. TOD Dergisi 2010;40:113-7.
  4. Özdemir H, Karaçorlu M, Karaçorlu S. İntranasal steroid kullanı- mı sonrası santral seröz koryoretinopati. T Oft Gaz 2005; 35: 72-4.
  5. Rueda-Rueda T, Sánchez-Vicente JL, Llerena-Manzorro L et al. Bilateral exudative retinal detachment associated with central se- rous chorioretinopathy in a patient treated with corticosteroids. Arch Soc Esp Oftalmol 2017. doi: 10.1016/j.oftal.2017.01.002. [Basım aşamasında] Bordaberry MF. Vogt-Koyanagi-Harada disease: Diagnosis and treatments update. Curr Opin Ophthalmol. 2010;21:430-35.
  6. Ozdal P, Ozdamar Y, Yazici A et al. Vogt-Koyanagi-Harada disea- se:clinical and demographic characteristics of patients in a specia- lized eye hospital in Turkey. Ocul Immunol Infl amm. 2014;22:277- 86. Yamaguchi Y, Otani T, Kishi S. Tomographic features of serous re- tinal detachment with multilobular dye pooling in acute Vogt-Ko- yanagi-Harada disease. Am J Ophthalmol. 2007;144:260-5.
  7. Kocatürk T, Oruç Dündar S, Çakmak H ve ark. Vogt Koyanagi Harada sendromlu bir olguda OKT bulguları. Ret-Vit Özel Sayı 2015;23:201-4.
  8. Ishihara K, Hangai M, Kita M et al. Acute Vogt-Koyanagi-Harada disease in enhanced spectral-domain optical coherence tomograp- hy. Ophthalmology. 2009;116:1799-807.
  9. Lin D, Chen W, Zhang G et al. Comparison of the optical coheren- ce tomographic characters between acute Vogt-Koyanagi-Harada disease and acute central serous chorioretinopathy. BMC Ophthal- mol. 2014;14:87. Balaratnasingam C, Freund KB, Tan AM et al. Bullous Variant of Central Serous Chorioretinopathy: Expansion of Phenotypic Featu- res Using Multimethod Imaging. Ophthalmology. 2016;123:1541- 52. Jampol LM, Weinreb R, Yannuzzi L. Involvement of corticosteroi- ds and catecholamines in the pathogenesis of central serous chori- oretinopathy: a rationale for new treatment strategies. Ophthalmo- logy. 2002;109:1765-6.
  10. Aggarwal K, Agarwal A, Deokar A et al. OCTA Study Group. Dis- tinguishing features of acute Vogt-Koyanagi-Harada disease and acute central serous chorio